Ladanyi M - Search Results

1

The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer.

Schoenfeld AJ, Bandlamudi C, Lavery JA, Montecalvo J, Namakydoust A, Rizvi H, Egger J, Concepcion CP, Paul S, Arcila ME, Daneshbod Y, Chang J, Sauter JL, Beras A, Ladanyi M, Jacks T, Rudin CM, Taylor BS, Donoghue MTA, Heller G, Hellmann MD, Rekhtman N, Riely GJ. Schoenfeld AJ, et al. Among authors: ladanyi m. Clin Cancer Res. 2020 Nov 1;26(21):5701-5708. doi: 10.1158/1078-0432.CCR-20-1825. Epub 2020 Jul 24. Clin Cancer Res. 2020. PMID: 32709715 Free PMC article.

2

MDM2 gene amplification in metastatic osteosarcoma.

Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH. Ladanyi M, et al. Cancer Res. 1993 Jan 1;53(1):16-8. Cancer Res. 1993. PMID: 8416741

3

p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.

Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M. Lonardo F, et al. Among authors: ladanyi m. Cancer. 1997 Apr 15;79(8):1541-7. Cancer. 1997. PMID: 9118036

4

CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.

Wei G, Lonardo F, Ueda T, Kim T, Huvos AG, Healey JH, Ladanyi M. Wei G, et al. Among authors: ladanyi m. Int J Cancer. 1999 Jan 18;80(2):199-204. doi: 10.1002/(sici)1097-0215(19990118)80:2<199::aid-ijc7>3.0.co;2-4. Int J Cancer. 1999. PMID: 9935200 Free article. Clinical Trial.

5

Mechanisms of methotrexate resistance in osteosarcoma.

Guo W, Healey JH, Meyers PA, Ladanyi M, Huvos AG, Bertino JR, Gorlick R. Guo W, et al. Among authors: ladanyi m. Clin Cancer Res. 1999 Mar;5(3):621-7. Clin Cancer Res. 1999. PMID: 10100715

6

Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.

Antonescu CR, Elahi A, Healey JH, Brennan MF, Lui MY, Lewis J, Jhanwar SC, Woodruff JM, Ladanyi M. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2000 Jul;6(7):2788-93. Clin Cancer Res. 2000. PMID: 10914725

7

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2001 Dec;7(12):3977-87. Clin Cancer Res. 2001. PMID: 11751490

8

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O. Ladanyi M, et al. Cancer Res. 2002 Jan 1;62(1):135-40. Cancer Res. 2002. PMID: 11782370

9

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Illei PB, et al. Among authors: ladanyi m. Clin Cancer Res. 2003 Jun;9(6):2108-13. Clin Cancer Res. 2003. PMID: 12796375

10

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.

Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, DeMatteo RP, Besmer P. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2003 Aug 15;9(9):3329-37. Clin Cancer Res. 2003. PMID: 12960119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

736 results

Search Page